| Literature DB >> 31817147 |
María Del Carmen Valls Martínez1, Alicia Ramírez-Orellana1.
Abstract
The aim of this article was to determine which key indicators influence patient satisfaction with the Spanish NHS to provide useful information for policy decision-making. A total of 33 variables for each of the 17 Spanish autonomous communities were collected from the statistical portal of the Spanish Ministry of Health, Social Services, and Equality between 2005 and 2016. A cross-sectional study was applied using Partial Least Squares to a Structural Equation Model (PLS-SEM). The influence of expenditures, resource allocation, and safety were hypothesized about patient satisfaction. Gross Domestic Product (GDP) and life expectancy were used as control variables. Moreover, the influence of resource allocation on use was tested. The model explained 57.1% of patient satisfaction with the Spanish NHS. It was positively influenced mainly by resource allocation and expenditures, followed by safety and life expectancy. Additionally, resources directly influenced the level of use. The number of hospital beds, hemodialysis equipment, rate of adverse drug reactions, and expenditure positively influenced patient satisfaction. In contrast, the number of posts in day hospitals, the hospital infection rate, and the percentage of pharmacy spending negatively influenced patient satisfaction.Entities:
Keywords: National Health Service; health policy; partial least squares structural equation modeling (PLS-SEM); patient satisfaction; quality of healthcare
Mesh:
Year: 2019 PMID: 31817147 PMCID: PMC6950388 DOI: 10.3390/ijerph16244886
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 3.390
Healthcare index by country.
| Region | Analyzed Countries | Range |
|---|---|---|
| World | 89 | 86.69–39.35 |
| Africa | 7 | 63.27–40.17 |
| America | 15 | 71.27–40.17 |
| Asia | 30 | 86.89–41.32] |
| Europe | 35 | 79.46–47.62 |
| Oceania | 2 | 76.82–73.71 |
Data description and source.
| Composites | Indicators | Description |
|---|---|---|
| Patient satisfaction (mode A) | PS1 | Degree of satisfaction of citizens with the functioning of the public health system. |
| PS2 | Degree of citizen satisfaction with knowledge of the history and monitoring of their health problems by the family doctor and pediatrician. | |
| PS3 | Degree of satisfaction of the citizen with the information received in consultation with a specialist doctor about his health problem. | |
| Expenditures (mode B) | EX1 | Territorialized public health expenditure, per protected inhabitant. |
| EX2 * | Percentage of the cost of specialized care services. | |
| EX3 | Percentage of health expenditure in primary care. | |
| EX4 | Percentage of spending dedicated to concerts. | |
| EX5 | Percentage of expenditure on intermediate consumption. | |
| EX6 | Percentage of pharmacy spending. | |
| EX7 * | Percentage of staff compensation expense. | |
| EX8 | Percentage of health expenditure destined to training residents. | |
| Resources (mode B) | RE1 | Number of medical staff in specialized care for 1000 inhabitants. |
| RE2 | Number of hospital beds in operation per 1000 inhabitants. | |
| RE3 * | Number of operating theaters for 100,000 inhabitants. | |
| RE4 | Number of posts in day hospitals per 1000 inhabitants. | |
| RE5 * | Number of computerized axial tomography (CT) equipment in operation per 100,000 inhabitants. | |
| RE6 | Number of hemodialysis equipment in operation per 100,000 inhabitants. | |
| RE7 | Number of hemodynamic equipment in operation per 100,000 inhabitants. | |
| RE8 | Number of nuclear magnetic resonance (NMR) equipment per 100,000 inhabitants. | |
| Level of use (mode B) | LU1 * | Frequency of hospital admissions per 1000 inhabitants/year. |
| LU2 | Outpatient surgery percentage. | |
| LU3 * | Surgical interventions rate per 1000 inhabitants/year. | |
| LU4 * | Rate of use of CT per 1000 inhabitants/year. | |
| LU5 | Rate of use of hemodialysis per 1000 inhabitants/year. | |
| LU6 | Rate of use of hemodynamics per 1000 inhabitants/year. | |
| LU7 | Rate of use of NMR for 1000 inhabitants/year. | |
| LU8 | Frequency in specialized care consultations per 1000 inhabitants/year. | |
| Safety (mode B) | SA1 | Hospital infection rate. |
| SA2 | Overall in-hospital mortality per 100 hospital discharges. | |
| SA3 * | In-hospital mortality after surgical intervention per 100 surgical discharges. | |
| SA4 | Reporting rate of adverse drug reactions. | |
| GDP per capita (control variable) | GDP | Gross domestic product per capita. |
| Life expectancy (control variable) | LE | Life expectancy at birth. |
Source: Ministry of Health, Social Services, and Equality (MHSE), 2005–2016. * These indicators were not included in latent variables due to the multicollinearity criteria of PLS-SEM.
Mean, standard deviation, and variation in the period 2005–2016.
| Composites | Indicators | Mean 2005 | Standard Deviation 2005 | Mean 2016 | Standard Deviation 2016 | Variation 2005–2016 |
|---|---|---|---|---|---|---|
| Patient satisfaction | PS1 | 6.25 | 0.45 | 6.73 | 0.38 | 7.68 |
| PS2 | 7.14 | 0.37 | 7.72 | 0.25 | 8.12 | |
| PS3 | 7.06 | 0.48 | 7.31 | 0.35 | 3.54 | |
| Expenditures | EX1 | 1157.56 | 80.89 | 1462.79 | 131.19 | 26.37 |
| EX2 | 56.66 | 3.17 | 63.55 | 3.33 | 12.16 | |
| EX3 | 14.31 | 2.01 | 14.07 | 1.74 | −1.68 | |
| EX4 | 7.53 | 7.51 | 7.38 | 5.09 | −1.99 | |
| EX5 | 19.22 | 2.36 | 25.95 | 3.23 | 35.02 | |
| EX6 | 22.97 | 2.77 | 16.83 | 1.99 | −26.73 | |
| EX7 | 44.72 | 5.96 | 47.74 | 4.42 | 6.75 | |
| EX8 | 1.20 | 0.36 | 1.70 | 0.40 | 41.67 | |
| Resources | RE1 | 90.78 | 6.58 | 92.22 | 6.10 | 1.59 |
| RE2 | 73.94 | 10.84 | 79.47 | 9.85 | 7.48 | |
| RE3 | 67.88 | 8.98 | 73.01 | 9.41 | 7.56 | |
| RE4 | 78.90 | 19.92 | 87.06 | 10.84 | 10.34 | |
| RE5 | 67.90 | 12.03 | 73.03 | 11.24 | 7.56 | |
| RE6 | 84.21 | 15.51 | 90.44 | 11.39 | 7.40 | |
| RE7 | 61.58 | 22.87 | 66.11 | 16.45 | 7.36 | |
| RE8 | 46.60 | 16.35 | 56.05 | 13.43 | 20.28 | |
| Level of use | LU1 | 76.61 | 11.34 | 79.31 | 10.98 | 3.52 |
| LU2 | 35.19 | 7.54 | 43.07 | 6.24 | 22.39 | |
| LU3 | 70.01 | 10.86 | 72.76 | 10.87 | 3.93 | |
| LU4 | 83.68 | 10.69 | 85.29 | 9.80 | 1.92 | |
| LU5 | 78.67 | 25.07 | 89.23 | 14.61 | 13.42 | |
| LU6 | 74.73 | 24.94 | 86.61 | 12.61 | 15.90 | |
| LU7 | 15.43 | 3.15 | 39.11 | 15.67 | 153.47 | |
| LU8 | 1459.08 | 232.05 | 1722.69 | 242.03 | 18.07 | |
| Safety | SA1 | 1.19 | 0.32 | 1.05 | 0.26 | −11.76 |
| SA2 | 4.13 | 0.46 | 4.78 | 0.61 | 15.74 | |
| SA3 | 1.77 | 0.30 | 1.72 | 0.25 | −2.82 | |
| SA4 | 243.53 | 174.71 | 588.37 | 418.93 | 141.60 | |
| GDP per capita | GDP | 20.99 | 4.01 | 23.50 | 4.96 | 11.96 |
| Life expectancy | LE | 80.45 | 0.84 | 83.49 | 0.78 | 3.78 |
Figure 1Research model and hypotheses.
Figure 2* p < 0.05; ** p < 0.01; *** p < 0.001; ns not significant. Whole model results.
Measurement validation.
| Composite 1 | Cronbach’s Alpha | Dijkstra–Henseler’s Rho | Composite Reliability (CR) | Average Variance Extracted (AVE) |
|---|---|---|---|---|
| Patient satisfaction | 0.877 | 0.878 | 0.924 | 0.803 |
1 Patient satisfaction was measured as a mode A composite.
HTMT inference.
| HTMT Inference * | Original Sample | Sample Mean | 5.0% | 95.0% |
|---|---|---|---|---|
| Life expectancy → GDP per capita | 0.478 | 0.477 | 0.388 | 0.558 |
| Patient satisfaction → GDP per capita | 0.152 | 0.170 | 0.119 | 0.243 |
| Patient satisfaction → Life expectancy | 0.500 | 0.499 | 0.394 | 0.598 |
* Significance, 95% bias-corrected confidence interval performed by a bootstrapping procedure with 10,000 replications.
Significance of weights.
| Original Sample |
| Loadings | Lo95 | Hi95 | |
|---|---|---|---|---|---|
| Expenditures | |||||
| EX1 | 0.332 * | 1.910 | 0.673 | [0.006; | 0.578] |
| EX3 | 0.221 ns | 1.775 | 0.368 | −0.018 | 0.395 |
| EX4 | −0.419 ns | 1.642 | −0.261 | −0.652 | −0.113 |
| EX5 | −0.309 ns | 1.424 | 0.049 | −0.523 | 0.024 |
| EX6 | −0.834 * | 1.971 | −0.733 | −1.082 | −0.350 |
| EX8 | −0.051 ns | 0.308 | 0.213 | −0.287 | 0.261 |
| Resource Allocation | |||||
| RE1 | −0.054 ns | 0.397 | 0.344 | −0.283 | 0.164 |
| RE2 | 0.440 ** | 2.421 | 0.390 | 0.119 | 0.584 |
| RE4 | −0.248 * | 2.030 | 0.156 | −0.368 | −0.055 |
| RE6 | 0.990 ** | 2.725 | 0.871 | 0.661 | 1.116 |
| RE7 | −0.412 ns | 1.571 | −0.143 | −0.664 | −0.051 |
| RE8 | −0.075 ns | 0.342 | 0.463 | −0.423 | 0.294 |
| Safety | |||||
| SA1 | −0.520 ** | 2.907 | −0.461 | −0.681 | −0.304 |
| SA2 | 0.092 ns | 0.669 | 0.158 | −0.133 | 0.316 |
| SA4 | 0.865 *** | 4.239 | 0.863 | 0.713 | 0.969 |
| Level of use | |||||
| LU2 | 0.276 * | 2.183 | 0.593 | −0,024 | 0.390 |
| LU5 | 0.695 * | 2.263 | 0.869 | 0,355 | 0.948 |
| LU6 | −0.329 ns | 1.261 | −0.161 | −0.639 | 0.058 |
| LU7 | 0.323 * | 1.710 | 0.564 | −0.062 | 0.555 |
| LU8 | −0.007 ns | 0.052 | 0.348 | −0.259 | 0.197 |
* p < 0.05; ** p < 0.01; *** p < 0.001; ns not significant. Significance, t statistic, and 95% bias-corrected confidence interval performed by a bootstrapping procedure with 10,000 replications.
Whole sample results.
| Path |
|
| Lo95 | Hi95 |
| VIF | |
|---|---|---|---|---|---|---|---|
| Direct effects | |||||||
| EX → PS | 0.303 * | 2.055 | 0.020 | 0.157 | 0.40 | 0.128 | 1.676 |
| RE → PS | 0.338 ** | 2.947 | 0.002 | 0.125 | 0.423 | 0.198 | 1.342 |
| SA → PS | 0.272 *** | 3.370 | 0.000 | 0.184 | 0.355 | 0.151 | 1.146 |
| GDP → PS | −0.086 ns | 0.956 | 0.170 | −0.246 | 0.051 | 0.013 | 1.347 |
| LE → PS | 0.180 * | 2.112 | 0.017 | 0.051 | 0.330 | 0.044 | 1.700 |
|
| |||||||
| EX → RE | 0.475 *** | 3.734 | 0.000 | 0.349 | 0.672 | 0.292 | 1.000 |
|
| |||||||
| RE → LU | 0.817 *** | 21.662 | 0.000 | 0.768 | 0.892 | 2.003 | 1.000 |
|
| |||||||
| Indirect effect | VAF | ||||||
| EX → RE → PS | 0.161 ** | 2.450 | 0.007 | 0.065 | 0.223 | 35.2% | na |
* p < 0.05; ** p < 0.01; *** p < 0.001; ns not significant. Significance, t statistic, and 95% bias-corrected confidence interval performed by a bootstrapping procedure with 10,000 replications. VIF: Inner model variance inflation factor; VAF: variance accounted for.